SCDC Materials and Multimedia
Fact Sheets
A Snapshot of Sickle Cell Disease in:
Hospital and Emergency Department Utilization for People with Sickle Cell Disease
During 2006–2016, the use of hydroxyurea (HU) among Medicaid beneficiaries with sickle cell disease (SCD) who lived in California or Georgia increased. However, many beneficiaries with severe complications of SCD do not use HU.
The Centers for Disease Control and Prevention (CDC) estimates that sickle cell disease (SCD) affects more than 100,000 people in the United States, but the exact number of people with SCD is unknown. CDC’s Sickle Cell Data Collection (SCDC) program gathers health information from multiple sources to determine how many people live with the disease in a particular state.
The Sickle Cell Data Collection (SCDC) program collects information about people with SCD to help communities, healthcare providers, policy makers, researchers, and federal, state, and local health agencies better understand who has SCD, what their healthcare needs are, and what barriers prevent them from receiving all their needed healthcare services. These data are used to target and develop strategies to improve access to the healthcare system and, ultimately, to improve health for people with SCD.
What to know before you go. Children and adults with sickle cell disease (SCD) often require care in the emergency department (ED) of hospitals or clinics for health issues related to SCD. The ED may be your only option for health care when symptoms, such as pain crises, cannot be managed at home or when you do not have access to a healthcare provider who specializes in treating SCD.
Every emergency provider needs to know. Children and adults with sickle cell disease (SCD) often require care in the emergency department (ED) of hospitals and clinics for health issues related to SCD. The ED may be a patient’s only option for health care when symptoms, such as pain crises, cannot be managed at home or when a patient does not have access to a healthcare provider who specializes in treating SCD.
The Centers for Disease Control and Prevention (CDC) and participating states began sickle cell disease (SCD) surveillance (monitoring) in 2010. SCD surveillance involves collecting information on diagnoses, treatment, and healthcare access for people with SCD in the United States. CDC and participating states developed many educational materials based on this information.
Reports
The Sickle Cell Data Collection (SCDC) program gathers health data from multiple sources to determine how many people live with sickle cell disease (SCD) in the United States and to learn about their use of healthcare services and health outcomes over time. The SCDC program shares this information with audiences who can drive improvements in SCD health care, treatment, and policy.
No hay comentarios:
Publicar un comentario